A new study published in BMC Women’s Health reveals that self-collected medical-grade tampons are an effective and highly acceptable tool for detecting Human Papillomavirus (HPV) and sexually transmitted infections (STIs). This innovative approach could significantly improve access to crucial screening, particularly in low-resource settings.
Cervical cancer remains a major global health concern, especially in low- and middle-income countries (LMICs). Current screening methods often involve healthcare worker-collected samples, which can present emotional and practical barriers for many women. This new research explores the potential of a self-collected tampon as a more accessible and comfortable alternative.
The study, conducted by researchers including Valentina Milanova, Iva Lazarova, Kalina Mihaylova, Michelle Gomes, Teodora Georgieva and Jan Multmeier, involved 60 female participants aged 18-54. Participants provided both healthcare worker-collected (HCW) samples and self-collected tampon samples, which were then tested for HPV and common STIs like bacterial vaginosis (BV), chlamydia (CT), and gonorrhea (NG).
Key Findings:
- High Diagnostic Accuracy: Self-collected tampons demonstrated promising diagnostic accuracy comparable to HCW-collected swabs for detecting HPV and STIs.
- For HPV detection, tampons showed a sensitivity of 66.67% and specificity of 90.74% when rinsed in ThinPrep Vial solution, and 83.33% sensitivity and 85.42% specificity when rinsed in APTIMA® solution.
- For bacterial vaginosis (BV), tampons achieved 100.0% sensitivity and 96.43% specificity (ThinPrep Vial), and 88.89% sensitivity and 98.04% specificity (APTIMA®).
- For chlamydia and gonorrhea (AC2), tampons showed 100.00% sensitivity and 100.0% specificity (ThinPrep Vial), and 100.00% sensitivity and 98.31% specificity (APTIMA®).
- High Acceptability and Preference: A significant majority of participants (90%) expressed a preference for tampon self-collection over HCW-collected swabs. Participants generally felt more positive about using menstrual tampons than undergoing gynecological exams for sampling.
- Impact of Storage Solution: The study highlighted that the storage solution used for the tampons influenced the overall detection rate, with the APTIMA® Tube showing a two-fold increase in HPV detection compared to the ThinPrep Vial.
“Our findings demonstrate that self-collected tampons offer a viable and well-accepted alternative for HPV and STI screening,” said Michelle Gomes, one of the lead authors. “This method could significantly reduce barriers to screening, particularly in areas with limited healthcare resources, by offering a more private and convenient option for women.”
The researchers emphasise that while these initial results are promising, further research with larger and more diverse populations is needed to fully validate these findings and inform the widespread implementation of tampon-based self-collection programs. This study represents a crucial step towards making cervical cancer and STI screening more accessible and equitable globally.
BMC Women’s Health is an open access, peer-reviewed journal that considers articles on all aspects of the health of women and girls.
Download full paper here.